Page last updated: 2024-10-30

vitamin k 3 and ER-Negative PR-Negative HER2-Negative Breast Cancer

vitamin k 3 has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 3 studies

Vitamin K 3: A synthetic naphthoquinone without the isoprenoid side chain and biological activity, but can be converted to active vitamin K2, menaquinone, after alkylation in vivo.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Beebe, J1
Josephraj, S1
Wang, CJ1
Danielson, J1
Cui, Q1
Huang, C1
Barlow, L1
Zhang, RH1
Zhang, T1
Nakshatri, H1
Dong, Z1
Li, X1
Liu, JY1
Zhang, JT1
Bohl, L1
Guizzardi, S1
Rodríguez, V1
Hinrichsen, L1
Rozados, V1
Cremonezzi, D1
Tolosa de Talamoni, N1
Picotto, G1
Yamada, A1
Osada, S1
Tanahashi, T1
Matsui, S1
Sasaki, Y1
Tanaka, Y1
Okumura, N1
Matsuhashi, N1
Takahashi, T1
Yamaguchi, K1
Yoshida, K1

Other Studies

3 other studies available for vitamin k 3 and ER-Negative PR-Negative HER2-Negative Breast Cancer

ArticleYear
Therapeutic Activity of the Lansoprazole Metabolite 5-Hydroxy Lansoprazole Sulfide in Triple-Negative Breast Cancer by Inhibiting the Enoyl Reductase of Fatty Acid Synthase.
    Journal of medicinal chemistry, 2022, 10-27, Volume: 65, Issue:20

    Topics: Fatty Acid Synthases; Humans; Lansoprazole; Lipids; Oxidoreductases; Proton Pump Inhibitors; Sulfide

2022
Combined calcitriol and menadione reduces experimental murine triple negative breast tumor.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2017, Volume: 94

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Calcitriol; Calcium; Cell Nucleus; DNA Frag

2017
Novel therapy for locally advanced triple-negative breast cancer.
    International journal of oncology, 2015, Volume: 47, Issue:4

    Topics: Animals; Antineoplastic Agents; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Extracellul

2015